RIGL, LWSN, ANAD, SYNA, PTIE, ABCO Are Seasonally Ripe To Go Down In the Next Five Weeks
February 15, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL), LAWSON SOFTWARE INC (NASDAQ:LWSN), ANADIGICS INC (NASDAQ:ANAD), SYNAPTICS INC (NASDAQ:SYNA), PAIN THERAPEUTICS INC (NASDAQ:PTIE), ADVISORY BOARD CO/THE (NASDAQ:ABCO) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php
The following stocks are expected to go Down:
Symbol Company Expected Return Odds By The Following Date RIGL RIGEL PHARMACEUTICALS INC -18.320 % 90.00% (9 of 10) Thursday, March 10th 2011 LWSN LAWSON SOFTWARE INC -8.250 % 88.89% (8 of 9) Thursday, March 10th 2011 ANAD ANADIGICS INC -9.490 % 80.00% (12 of 15) Thursday, March 10th 2011 SYNA SYNAPTICS INC -5.350 % 88.89% (8 of 9) Thursday, March 10th 2011 PTIE PAIN THERAPEUTICS INC -11.850 % 70.00% (7 of 10) Thursday, March 10th 2011 ABCO ADVISORY BOARD CO/THE -6.120 % 88.89% (8 of 9) Thursday, March 10th 2011
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) - Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its product development programs include R788, which completed a phase 2 clinical trial for the treatment of rheumatoid arthritis; and is in phase 2 clinical trials for B-cell lymphoma, T-cell lymphoma, immune thrombocytopenia purpura, and certain solid tumors. The companys product development programs also comprise R343, which is in phase 1b clinical trial for the treatment of asthma. In addition, its preclinical programs include oral JAK3 inhibitor program for research in the area of immunology/inflammation; adiponectin mimetics for the treatment of type 2 diabetes mellitus and other potential indications; and muscle atrophy program for muscle homeostasis. Further, the company is evaluating R763/AS703569 compound in its aurora kinase inhibition program targeting cancer cell proliferation. Rigel Pharmaceuticals, Inc. has collaboration agreements with AstraZeneca AB; Pfizer, Inc.; and Daiichi Pharmaceuticals Co., Ltd. The company was founded in 1996 and is based in South San Francisco, California.
LAWSON SOFTWARE INC (NASDAQ:LWSN) - Lawson Software, Inc. provides enterprise software, services, and support. The company offers a range of software applications and industry-specific solutions that help its customers in enhancing their business processes. Its software includes enterprise financial management, business intelligence, asset management, enterprise performance management, supply chain management, service management, manufacturing operations, business project management, and industry-tailored applications. The companys software also comprises talent management, human resource management, and workforce management software. Lawson Software also provides consulting, maintenance, and support services. The company serves various industries, which principally include equipment service management and rental, fashion, food and beverage, healthcare, manufacturing and distribution, public sector, and service industries. Lawson Software, Inc. markets and sells its software and services primarily through a direct sales force, and strategic alliances with systems integrators and resellers. It offers its products primarily in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company was founded in 1975 and is headquartered in Saint Paul, Minnesota.
ANADIGICS INC (NASDAQ:ANAD) - ANADIGICS, Inc. provides semiconductor solutions to the broadband wireless and wireline communications markets. Its products include power amplifiers, tuner integrated circuits, active splitters, line amplifiers, and other components. The company designs, develops, and manufactures radio frequency integrated circuits primarily using gallium arsenide compound semiconductor substrates with various process technologies, metal semiconductor field effect transistors, pseudomorphic high electron mobility transistors, and heterojunction bipolar transistors. It offers third generation products that use the wideband code-division multiple access (W-CDMA) and enhanced data rates for global system for mobile communication evolution (EDGE) standards, as well as combinations of W-CDMA and EDGE platforms (WEDGE); third generation (3.5G) products that use the high speed packet access (HSPA) and Evolution Data Optimized (EVDO) standards; fourth generation (4G) products for worldwide interoperability for microwave access; wireless fidelity products; cable television (CATV) cable modem and set-top box products; CATV infrastructure products; and Fiber-To-The-Premises products. The company sells its products through direct sales, as well as through independent manufacturers representatives and distributors. It has a strategic agreement with WIN Semiconductors Corp. The company was founded in 1984 and is headquartered in Warren, New Jersey.
SYNAPTICS INC (NASDAQ:SYNA) - Synaptics Incorporated develops and supplies custom-designed human interface solutions that enable people to interact with various mobile computing, communications, entertainment, and other electronic devices. The company provides custom interface solutions for navigation, cursor control, and multimedia controls for PC original equipment manufacturers (OEMs). It primarily targets the personal computer (PC) market and the market for digital lifestyle products, including mobile smartphones and feature phones, portable digital music and video players, and other select electronic device markets with its customized interface solutions. In addition to notebooks, other PC applications for the companys technology include peripherals, such as keyboards, mice, and monitors, as well as desktop and PC remote control applications. Its solutions for the PC market primarily include the TouchPad, a touch-sensitive pad that senses the position of a persons finger on its surface; the TouchStyk, an integrated pointing stick module; and dual pointing solutions, which combine both a TouchPad and a pointing stick into a single notebook computer enabling the users to use the interface of their choice. The companys user interface solutions for digital lifestyle products comprise the ScrollStrip and TouchRing, which are scrolling solutions that enable users to navigate through menus and content; LightTouch capacitive buttons, which provide illuminated button functionality; and MobileTouch, NavPoint, and ClearTouch solutions. Synaptics sells its products to PC OEMs, as well as to various consumer electronics manufacturers primarily in the United States, Taiwan, China, Korea, Japan, Hong Kong, Switzerland, Singapore, and Malaysia. The company was founded in 1986 and is based in Santa Clara, California.
PAIN THERAPEUTICS INC (NASDAQ:PTIE) - Pain Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of novel drugs. It has four drug candidates in clinical development programs, which include Remoxy, a novel controlled-release oral capsule form of oxycodone; PTI-202 and PTI-721, which are abuse-resistant forms of opioid drugs; and PTI-188 for the treatment of metastatic melanoma. The company is also developing a technology for the treatment of hemophilia in patients. Pain Therapeutics, Inc. has a strategic alliance with King Pharmaceuticals, Inc. for the development and commercialization of Remoxy, PTI-202, PTI-721, and other abuse-resistant opioid painkillers. The company was founded in 1998 and is based in San Mateo, California.
ADVISORY BOARD CO/THE (NASDAQ:ABCO) - The Advisory Board Company provides best practices research, analysis, executive education and leadership development, business intelligence software tools, and installation support services primarily to the health care industry. Its programs focus on business strategy, operations, and general management issues. The companys program services include best practices research studies, executive education, proprietary content databases and online tools, daily online executive briefings, executive inquiry service, business intelligence and analytic tools, and best practices installation support. Its best practices research services focus on identifying best-demonstrated management practices, critiquing widely-followed but ineffective practices, and analyzing emerging trends in the health care and education industries; business intelligence and analytics programs enable members to pair their own operational data with the best practices insights; and installation support programs assist member institutions to adopt and implement best practices to enhance performance. As of September 30, 2009, the company offered 43 programs to a membership of approximately 2,800 organizations, including hospitals, health systems, pharmaceutical and biotech companies, health care insurers, medical device companies, universities, and other education institutions. The Advisory Board Company was founded in 1979 and is headquartered in Washington, District of Columbia.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641